Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

December 01, 2004; Volume 32,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adachi, Yasuhisa

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468
  2. Alley, Michael C.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  3. Alvarez-Diez, Teresa M.

    1. You have access
      DETECTION OF GLUTATHIONE CONJUGATES DERIVED FROM 4-IPOMEANOL METABOLISM IN BILE OF RATS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      Teresa M. Alvarez-Diez and Jiang Zheng
      Drug Metabolism and Disposition December 2004, 32 (12) 1345-1350; DOI: https://doi.org/10.1124/dmd.104.000406
  4. Andersson, Tommy B.

    1. You have access
      RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena SjÖberg
      Drug Metabolism and Disposition December 2004, 32 (12) 1523; DOI: https://doi.org/10.1124/dmd.104.002329
  5. Antonio, Laurence

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
  6. Apak, T. Idil

    1. You have access
      INTERACTIONS OF THE STEREOISOMERS OF α-HYDROXYTAMOXIFEN WITH HUMAN HYDROXYSTEROID SULFOTRANSFERASE SULT2A1 AND RAT HYDROXYSTEROID SULFOTRANSFERASE STA
      T. Idil Apak and Michael W. Duffel
      Drug Metabolism and Disposition December 2004, 32 (12) 1501-1508; DOI: https://doi.org/10.1124/dmd.104.000919
  7. Ardlie, Kristin G.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099

B

  1. Bai, Stephen A.

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  2. Basu, N. K.

    1. You have access
      RESPONSE TO THE LETTER TO THE EDITOR BY DRS. N. PICARD AND P. MARQUET REGARDING A PUBLICATION: BASU ET AL., DRUG METABOLISM AND DISPOSITION (32:768–773, (2004)
      N. K. Basu, L. Kole, S. Kubota and I. S. Owens
      Drug Metabolism and Disposition December 2004, 32 (12) 1525; DOI: https://doi.org/10.1124/dmd.104.002345
  3. Berry, Pamela W.

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  4. Bradshaw, Tracey D.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  5. Brantley, Eileen

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  6. Bredberg, Eva

    1. You have access
      RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena SjÖberg
      Drug Metabolism and Disposition December 2004, 32 (12) 1523; DOI: https://doi.org/10.1124/dmd.104.002329
  7. Brown, Caroline

    1. You have access
      UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES
      Aleksandra Galetin, Caroline Brown, David Hallifax, Kiyomi Ito and J. Brian Houston
      Drug Metabolism and Disposition December 2004, 32 (12) 1411-1420; DOI: https://doi.org/10.1124/dmd.104.000844
  8. Burchell, Brian

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
    2. You have access
      IDENTIFICATION OF THE RABBIT LIVER UDP-GLUCURONOSYLTRANSFERASE CATALYZING THE GLUCURONIDATION OF 4-ETHOXYPHENYLUREA (DULCIN)
      Yoshihiro Uesawa, Adam G. Staines, Audrey O'Sullivan, Kiminori Mohri and Brian Burchell
      Drug Metabolism and Disposition December 2004, 32 (12) 1476-1481; DOI: https://doi.org/10.1124/dmd.104.001206

C

  1. Cabacungan, Erwin T.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  2. Calamia, Justina C.

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  3. Chauret, Nathalie

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  4. Chavin, Kenneth D.

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  5. Chen, Chuan

    1. You have access
      TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE
      Hong Lu, Chuan Chen and Curtis Klaassen
      Drug Metabolism and Disposition December 2004, 32 (12) 1455-1461; DOI: https://doi.org/10.1124/dmd.104.001123
  6. Cho, Joo-Youn

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  7. Christ, David D.

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  8. Chung, Jae-Yong

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  9. Claes, Kathleen

    1. You have access
      THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS
      Dirk R. J. Kuypers, Kathleen Claes, P. Evenepoel, B. Maes and Yves Vanrenterghem
      Drug Metabolism and Disposition December 2004, 32 (12) 1421-1425; DOI: https://doi.org/10.1124/dmd.104.001503

D

  1. D'Antoni, Michelle

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  2. Day, Stephen H.

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  3. DeLegge, Mark H.

    1. You have access
      HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
      Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
      Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
  4. DeVane, C. Lindsay

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  5. Diamond, Sharon

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  6. Ding, Xinxin

    1. You have access
      IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
      Xiao-Yang He, Jian Shen, Xinxin Ding, Anthony Y. H. Lu and Jun-Yan Hong
      Drug Metabolism and Disposition December 2004, 32 (12) 1516-1521; DOI: https://doi.org/10.1124/dmd.104.001370
  7. Donovan, Jennifer L.

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  8. Duffel, Michael W.

    1. You have access
      INTERACTIONS OF THE STEREOISOMERS OF α-HYDROXYTAMOXIFEN WITH HUMAN HYDROXYSTEROID SULFOTRANSFERASE SULT2A1 AND RAT HYDROXYSTEROID SULFOTRANSFERASE STA
      T. Idil Apak and Michael W. Duffel
      Drug Metabolism and Disposition December 2004, 32 (12) 1501-1508; DOI: https://doi.org/10.1124/dmd.104.000919

E

  1. Elovaara, Eivor

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
  2. Ericsson, Hans

    1. You have access
      RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena SjÖberg
      Drug Metabolism and Disposition December 2004, 32 (12) 1523; DOI: https://doi.org/10.1124/dmd.104.002329
  3. Evenepoel, P.

    1. You have access
      THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS
      Dirk R. J. Kuypers, Kathleen Claes, P. Evenepoel, B. Maes and Yves Vanrenterghem
      Drug Metabolism and Disposition December 2004, 32 (12) 1421-1425; DOI: https://doi.org/10.1124/dmd.104.001503

F

  1. Fitch, William L.

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  2. Fournel-Gigleux, Sylvie

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992

G

  1. Galetin, Aleksandra

    1. You have access
      UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES
      Aleksandra Galetin, Caroline Brown, David Hallifax, Kiyomi Ito and J. Brian Houston
      Drug Metabolism and Disposition December 2004, 32 (12) 1411-1420; DOI: https://doi.org/10.1124/dmd.104.000844
  2. Gefroh, Holly A.

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  3. Ghoborah, Hesham

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  4. Gibson, Bryan B.

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  5. Gibson, Gordon

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  6. Gilbert, Darryl

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  7. Glodowski, Mary

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  8. Gohdes, Mark

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  9. Grace, James E.

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  10. Grossman, Scott J.

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943

H

  1. Hallifax, David

    1. You have access
      UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES
      Aleksandra Galetin, Caroline Brown, David Hallifax, Kiyomi Ito and J. Brian Houston
      Drug Metabolism and Disposition December 2004, 32 (12) 1411-1420; DOI: https://doi.org/10.1124/dmd.104.000844
  2. He, Kan

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  3. He, Xiao-Yang

    1. You have access
      IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
      Xiao-Yang He, Jian Shen, Xinxin Ding, Anthony Y. H. Lu and Jun-Yan Hong
      Drug Metabolism and Disposition December 2004, 32 (12) 1516-1521; DOI: https://doi.org/10.1124/dmd.104.001370
  4. Hines, Ronald N.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  5. Hirani, Vandana N.

    1. You have access
      CONVERSION OF THE HIV PROTEASE INHIBITOR NELFINAVIR TO A BIOACTIVE METABOLITE BY HUMAN LIVER CYP2C19
      Vandana N. Hirani, Judy L. Raucy and Jerome M. Lasker
      Drug Metabolism and Disposition December 2004, 32 (12) 1462-1467; DOI: https://doi.org/10.1124/dmd.104.001743
  6. Hirano, Masaru

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468
  7. Hiratsuka, Akira

    1. You have access
      IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
      Hiroshi Iwata, Yasuhiro Tezuka, Shigetoshi Kadota, Akira Hiratsuka and Tadashi Watabe
      Drug Metabolism and Disposition December 2004, 32 (12) 1351-1358; DOI: https://doi.org/10.1124/dmd.104.000646
  8. Hong, Jun-Yan

    1. You have access
      IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
      Xiao-Yang He, Jian Shen, Xinxin Ding, Anthony Y. H. Lu and Jun-Yan Hong
      Drug Metabolism and Disposition December 2004, 32 (12) 1516-1521; DOI: https://doi.org/10.1124/dmd.104.001370
  9. Horie, Toru

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  10. Hose, Curtis D.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  11. Houle, Robert

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  12. Houston, J. Brian

    1. You have access
      UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES
      Aleksandra Galetin, Caroline Brown, David Hallifax, Kiyomi Ito and J. Brian Houston
      Drug Metabolism and Disposition December 2004, 32 (12) 1411-1420; DOI: https://doi.org/10.1124/dmd.104.000844
  13. Howgate, Eleanor M.

    1. You have access
      PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
  14. Hsieh, Faye

    1. You have access
      HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
      Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
      Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
  15. Huang, Weili

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313

I

  1. Inagaki, Haruhisa

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  2. Isoherranen, Nina

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  3. Ito, Kiyomi

    1. You have access
      UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES
      Aleksandra Galetin, Caroline Brown, David Hallifax, Kiyomi Ito and J. Brian Houston
      Drug Metabolism and Disposition December 2004, 32 (12) 1411-1420; DOI: https://doi.org/10.1124/dmd.104.000844
  4. Itoh, Tomoo

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468
  5. Iwasaki, Kazuhide

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  6. Iwata, Hiroshi

    1. You have access
      IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
      Hiroshi Iwata, Yasuhiro Tezuka, Shigetoshi Kadota, Akira Hiratsuka and Tadashi Watabe
      Drug Metabolism and Disposition December 2004, 32 (12) 1351-1358; DOI: https://doi.org/10.1124/dmd.104.000646

J

  1. Jang, In-Jin

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  2. Jolley, Summer

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208

K

  1. Kadota, Shigetoshi

    1. You have access
      IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
      Hiroshi Iwata, Yasuhiro Tezuka, Shigetoshi Kadota, Akira Hiratsuka and Tadashi Watabe
      Drug Metabolism and Disposition December 2004, 32 (12) 1351-1358; DOI: https://doi.org/10.1124/dmd.104.000646
  2. Kataoka, Miho

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  3. Katoh, Miki

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  4. Kim, Jung-Ryul

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  5. Klaassen, Curtis

    1. You have access
      TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE
      Hong Lu, Chuan Chen and Curtis Klaassen
      Drug Metabolism and Disposition December 2004, 32 (12) 1455-1461; DOI: https://doi.org/10.1124/dmd.104.001123
  6. Koike, Masahiro

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  7. Kole, L.

    1. You have access
      RESPONSE TO THE LETTER TO THE EDITOR BY DRS. N. PICARD AND P. MARQUET REGARDING A PUBLICATION: BASU ET AL., DRUG METABOLISM AND DISPOSITION (32:768–773, (2004)
      N. K. Basu, L. Kole, S. Kubota and I. S. Owens
      Drug Metabolism and Disposition December 2004, 32 (12) 1525; DOI: https://doi.org/10.1124/dmd.104.002345
  8. Kominami, Goro

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  9. Krueger, Sharon K.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  10. Kubota, S.

    1. You have access
      RESPONSE TO THE LETTER TO THE EDITOR BY DRS. N. PICARD AND P. MARQUET REGARDING A PUBLICATION: BASU ET AL., DRUG METABOLISM AND DISPOSITION (32:768–773, (2004)
      N. K. Basu, L. Kole, S. Kubota and I. S. Owens
      Drug Metabolism and Disposition December 2004, 32 (12) 1525; DOI: https://doi.org/10.1124/dmd.104.002345
  11. Kumar, Gondi N.

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  12. Kuypers, Dirk R. J.

    1. You have access
      THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS
      Dirk R. J. Kuypers, Kathleen Claes, P. Evenepoel, B. Maes and Yves Vanrenterghem
      Drug Metabolism and Disposition December 2004, 32 (12) 1421-1425; DOI: https://doi.org/10.1124/dmd.104.001503

L

  1. Lasker, Jerome M.

    1. You have access
      CONVERSION OF THE HIV PROTEASE INHIBITOR NELFINAVIR TO A BIOACTIVE METABOLITE BY HUMAN LIVER CYP2C19
      Vandana N. Hirani, Judy L. Raucy and Jerome M. Lasker
      Drug Metabolism and Disposition December 2004, 32 (12) 1462-1467; DOI: https://doi.org/10.1124/dmd.104.001743
  2. LeCluyse, Edward L.

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  3. Lim, Hyeong-Seok

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  4. Lin, Yvonne S.

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  5. Liu, Yanzhou

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  6. Lopez-Tapia, Francisco

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  7. Lowrie, Lee

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  8. Lu, Anthony Y. H.

    1. You have access
      IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
      Xiao-Yang He, Jian Shen, Xinxin Ding, Anthony Y. H. Lu and Jun-Yan Hong
      Drug Metabolism and Disposition December 2004, 32 (12) 1516-1521; DOI: https://doi.org/10.1124/dmd.104.001370
  9. Lu, Hong

    1. You have access
      TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE
      Hong Lu, Chuan Chen and Curtis Klaassen
      Drug Metabolism and Disposition December 2004, 32 (12) 1455-1461; DOI: https://doi.org/10.1124/dmd.104.001123
  10. Luukkanen, Leena

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992

M

  1. Maes, B.

    1. You have access
      THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS
      Dirk R. J. Kuypers, Kathleen Claes, P. Evenepoel, B. Maes and Yves Vanrenterghem
      Drug Metabolism and Disposition December 2004, 32 (12) 1421-1425; DOI: https://doi.org/10.1124/dmd.104.001503
  2. Magdalou, Jacques

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
  3. Markowitz, John S.

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  4. Marquet, Pierre

    1. You have access
      IN VITRO STUDY OF MYCOPHENOLIC ACID GLUCURONIDATION
      Nicolas Picard and Pierre Marquet
      Drug Metabolism and Disposition December 2004, 32 (12) 1524; DOI: https://doi.org/10.1124/dmd.104.001982
  5. Martin, Sarah R.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  6. Masjedizadeh, Mohammad R.

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  7. Matsui, Tomohito

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  8. McConn, Donavon J.

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  9. Mehvar, Reza

    1. You have access
      SHORT-TERM INHIBITORY EFFECTS OF NITRIC OXIDE ON CYTOCHROME P450-MEDIATED DRUG METABOLISM: TIME DEPENDENCY AND REVERSIBILITY PROFILES IN ISOLATED PERFUSED RAT LIVERS
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition December 2004, 32 (12) 1446-1454; DOI: https://doi.org/10.1124/dmd.104.001487
  10. Mikkola, Jouni

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
  11. Milad, Mark A.

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  12. Mizobuchi, Minoru

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  13. Mohri, Kiminori

    1. You have access
      IDENTIFICATION OF THE RABBIT LIVER UDP-GLUCURONOSYLTRANSFERASE CATALYZING THE GLUCURONIDATION OF 4-ETHOXYPHENYLUREA (DULCIN)
      Yoshihiro Uesawa, Adam G. Staines, Audrey O'Sullivan, Kiminori Mohri and Brian Burchell
      Drug Metabolism and Disposition December 2004, 32 (12) 1476-1481; DOI: https://doi.org/10.1124/dmd.104.001206

N

  1. Nakajima, Miki

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  2. Nakajima, Yoshitsugu

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  3. Nakamura, Masahiro

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  4. Nicoll-Griffith, Deborah A.

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  5. Nitzan, Dov

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471

O

  1. O'Sullivan, Audrey

    1. You have access
      IDENTIFICATION OF THE RABBIT LIVER UDP-GLUCURONOSYLTRANSFERASE CATALYZING THE GLUCURONIDATION OF 4-ETHOXYPHENYLUREA (DULCIN)
      Yoshihiro Uesawa, Adam G. Staines, Audrey O'Sullivan, Kiminori Mohri and Brian Burchell
      Drug Metabolism and Disposition December 2004, 32 (12) 1476-1481; DOI: https://doi.org/10.1124/dmd.104.001206
  2. Oatis, John E.

    1. You have access
      HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
      Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
      Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
  3. Owens, I. S.

    1. You have access
      RESPONSE TO THE LETTER TO THE EDITOR BY DRS. N. PICARD AND P. MARQUET REGARDING A PUBLICATION: BASU ET AL., DRUG METABOLISM AND DISPOSITION (32:768–773, (2004)
      N. K. Basu, L. Kole, S. Kubota and I. S. Owens
      Drug Metabolism and Disposition December 2004, 32 (12) 1525; DOI: https://doi.org/10.1124/dmd.104.002345

P

  1. Padhi, Desmond

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  2. Pereira, Clifford B.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  3. Picard, Nicolas

    1. You have access
      IN VITRO STUDY OF MYCOPHENOLIC ACID GLUCURONIDATION
      Nicolas Picard and Pierre Marquet
      Drug Metabolism and Disposition December 2004, 32 (12) 1524; DOI: https://doi.org/10.1124/dmd.104.001982
  4. Poppe, Leszek

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604

Q

  1. Qian, Mingxin

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943

R

  1. Raucy, Judy L.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
    2. You have access
      CONVERSION OF THE HIV PROTEASE INHIBITOR NELFINAVIR TO A BIOACTIVE METABOLITE BY HUMAN LIVER CYP2C19
      Vandana N. Hirani, Judy L. Raucy and Jerome M. Lasker
      Drug Metabolism and Disposition December 2004, 32 (12) 1462-1467; DOI: https://doi.org/10.1124/dmd.104.001743
  2. Rose, Kelly A.

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  3. Roskos, Lorin

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  4. Rostami-Hodjegan, Amin

    1. You have access
      PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792

S

  1. Sadagopan, Nalini

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  2. Sahi, Jasminder

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  3. Sato, Hitoshi

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468
  4. Sausville, Edward A.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  5. Shen, Jian

    1. You have access
      IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
      Xiao-Yang He, Jian Shen, Xinxin Ding, Anthony Y. H. Lu and Jun-Yan Hong
      Drug Metabolism and Disposition December 2004, 32 (12) 1516-1521; DOI: https://doi.org/10.1124/dmd.104.001370
  6. Shin, Sang-Goo

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  7. Shitara, Yoshihisa

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468
  8. Siddens, Lisbeth K.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  9. Silva, José M.

    1. You have access
      USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
      Deborah A. Nicoll-Griffith, Nathalie Chauret, Robert Houle, Stephen H. Day, Michelle D'Antoni and José M. Silva
      Drug Metabolism and Disposition December 2004, 32 (12) 1509-1515; DOI: https://doi.org/10.1124/dmd.32.12.1509
  10. SjÖberg, Helena

    1. You have access
      RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena SjÖberg
      Drug Metabolism and Disposition December 2004, 32 (12) 1523; DOI: https://doi.org/10.1124/dmd.104.002329
  11. Soeno, Yoshinori

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  12. Sproul, Christopher

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604
  13. Staines, Adam G.

    1. You have access
      IDENTIFICATION OF THE RABBIT LIVER UDP-GLUCURONOSYLTRANSFERASE CATALYZING THE GLUCURONIDATION OF 4-ETHOXYPHENYLUREA (DULCIN)
      Yoshihiro Uesawa, Adam G. Staines, Audrey O'Sullivan, Kiminori Mohri and Brian Burchell
      Drug Metabolism and Disposition December 2004, 32 (12) 1476-1481; DOI: https://doi.org/10.1124/dmd.104.001206
  14. Stern, Ralph H.

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  15. Stevens, Malcolm F. G.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  16. Stilgenbauer, Linda

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
  17. Stinson, Sherman F.

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  18. Sugiyama, Yuichi

    1. You have access
      IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS
      Yoshihisa Shitara, Masaru Hirano, Yasuhisa Adachi, Tomoo Itoh, Hitoshi Sato and Yuichi Sugiyama
      Drug Metabolism and Disposition December 2004, 32 (12) 1468-1475; DOI: https://doi.org/10.1124/dmd.32.12.1468

T

  1. Tabatabaei, Ali

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  2. Takagi, Hidetoshi

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  3. Taskinen, Jyrki

    1. You have access
      ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
      Eivor Elovaara, Jouni Mikkola, Leena Luukkanen, Laurence Antonio, Sylvie Fournel-Gigleux, Brian Burchell, Jacques Magdalou and Jyrki Taskinen
      Drug Metabolism and Disposition December 2004, 32 (12) 1426-1433; DOI: https://doi.org/10.1124/dmd.104.000992
  4. Tateno, Chise

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  5. Tezuka, Yasuhiro

    1. You have access
      IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
      Hiroshi Iwata, Yasuhiro Tezuka, Shigetoshi Kadota, Akira Hiratsuka and Tadashi Watabe
      Drug Metabolism and Disposition December 2004, 32 (12) 1351-1358; DOI: https://doi.org/10.1124/dmd.104.000646
  6. Thummel, Kenneth E.

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  7. Totah, Rheem A.

    1. You have access
      EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
      Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski and Kenneth E. Thummel
      Drug Metabolism and Disposition December 2004, 32 (12) 1434-1445; DOI: https://doi.org/10.1124/dmd.104.001313
  8. Trapani, Valentina

    1. You have access
      FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
      Eileen Brantley, Valentina Trapani, Michael C. Alley, Curtis D. Hose, Tracey D. Bradshaw, Malcolm F. G. Stevens, Edward A. Sausville and Sherman F. Stinson
      Drug Metabolism and Disposition December 2004, 32 (12) 1392-1401; DOI: https://doi.org/10.1124/dmd.104.001057
  9. Tu, Yaping

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  10. Tucker, Geoffrey T.

    1. You have access
      PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
  11. Turner, Sharon

    1. You have access
      METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS
      Gondi N. Kumar, Christopher Sproul, Leszek Poppe, Sharon Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi and Lorin Roskos
      Drug Metabolism and Disposition December 2004, 32 (12) 1491-1500; DOI: https://doi.org/10.1124/dmd.104.000604

U

  1. Uesawa, Yoshihiro

    1. You have access
      IDENTIFICATION OF THE RABBIT LIVER UDP-GLUCURONOSYLTRANSFERASE CATALYZING THE GLUCURONIDATION OF 4-ETHOXYPHENYLUREA (DULCIN)
      Yoshihiro Uesawa, Adam G. Staines, Audrey O'Sullivan, Kiminori Mohri and Brian Burchell
      Drug Metabolism and Disposition December 2004, 32 (12) 1476-1481; DOI: https://doi.org/10.1124/dmd.104.001206

V

  1. Vanrenterghem, Yves

    1. You have access
      THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS
      Dirk R. J. Kuypers, Kathleen Claes, P. Evenepoel, B. Maes and Yves Vanrenterghem
      Drug Metabolism and Disposition December 2004, 32 (12) 1421-1425; DOI: https://doi.org/10.1124/dmd.104.001503
  2. Varadarajan, Aravamuthan

    1. You have access
      IDENTIFICATION OF GLUTATHIONE-DERIVED METABOLITES FROM AN IP RECEPTOR ANTAGONIST
      William L. Fitch, Pamela W. Berry, Yaping Tu, Ali Tabatabaei, Lee Lowrie, Francisco Lopez-Tapia, Yanzhou Liu, Dov Nitzan, Mohammad R. Masjedizadeh and Aravamuthan Varadarajan
      Drug Metabolism and Disposition December 2004, 32 (12) 1482-1490; DOI: https://doi.org/10.1124/dmd.104.000471
  3. Vuppugalla, Ragini

    1. You have access
      SHORT-TERM INHIBITORY EFFECTS OF NITRIC OXIDE ON CYTOCHROME P450-MEDIATED DRUG METABOLISM: TIME DEPENDENCY AND REVERSIBILITY PROFILES IN ISOLATED PERFUSED RAT LIVERS
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition December 2004, 32 (12) 1446-1454; DOI: https://doi.org/10.1124/dmd.104.001487

W

  1. Walle, Thomas

    1. You have access
      HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
      Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
      Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
  2. Walle, U. Kristina

    1. You have access
      HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
      Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
      Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
  3. Wang, Jun-Sheng

    1. You have access
      MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, C. Lindsay DeVane, Kenneth D. Chavin, Jun-Sheng Wang, Bryan B. Gibson, Holly A. Gefroh and John S. Markowitz
      Drug Metabolism and Disposition December 2004, 32 (12) 1333-1336; DOI: https://doi.org/10.1124/dmd.104.001164
  4. Watabe, Tadashi

    1. You have access
      IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT
      Hiroshi Iwata, Yasuhiro Tezuka, Shigetoshi Kadota, Akira Hiratsuka and Tadashi Watabe
      Drug Metabolism and Disposition December 2004, 32 (12) 1351-1358; DOI: https://doi.org/10.1124/dmd.104.000646
  5. Williams, David E.

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099
  6. Wong, Harvey

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  7. Wright, Matthew R.

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943

Y

  1. Yamaguchi, Toshiro

    1. You have access
      MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS
      Yoshitsugu Nakajima, Minoru Mizobuchi, Masahiro Nakamura, Hidetoshi Takagi, Haruhisa Inagaki, Goro Kominami, Masahiro Koike and Toshiro Yamaguchi
      Drug Metabolism and Disposition December 2004, 32 (12) 1383-1391; DOI: https://doi.org/10.1124/dmd.104.000661
  2. Yeleswaram, Krishnaswamy

    1. You have access
      THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
      Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram and David D. Christ
      Drug Metabolism and Disposition December 2004, 32 (12) 1359-1369; DOI: https://doi.org/10.1124/dmd.104.000943
  3. Yeo, Karen Rowland

    1. You have access
      PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
      Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
  4. Yokoi, Tsuyoshi

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  5. Yoshizato, Katsutoshi

    1. You have access
      EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Miho Kataoka, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2004, 32 (12) 1402-1410; DOI: https://doi.org/10.1124/dmd.104.001347
  6. Yu, Kyung-Sang

    1. You have access
      HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION
      Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, Kyung-Sang Yu, Jung-Ryul Kim, Sang-Goo Shin and In-Jin Jang
      Drug Metabolism and Disposition December 2004, 32 (12) 1341-1344; DOI: https://doi.org/10.1124/dmd.104.001107
  7. Yu, Zhen

    1. You have access
      DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
      Sharon K. Krueger, Lisbeth K. Siddens, Sarah R. Martin, Zhen Yu, Clifford B. Pereira, Erwin T. Cabacungan, Ronald N. Hines, Kristin G. Ardlie, Judy L. Raucy and David E. Williams
      Drug Metabolism and Disposition December 2004, 32 (12) 1337-1340; DOI: https://doi.org/10.1124/dmd.104.001099

Z

  1. Zheng, Jiang

    1. You have access
      DETECTION OF GLUTATHIONE CONJUGATES DERIVED FROM 4-IPOMEANOL METABOLISM IN BILE OF RATS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      Teresa M. Alvarez-Diez and Jiang Zheng
      Drug Metabolism and Disposition December 2004, 32 (12) 1345-1350; DOI: https://doi.org/10.1124/dmd.104.000406
  2. Zheng, Xianxian

    1. You have access
      EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
      Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
      Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (12)
Drug Metabolism and Disposition
Vol. 32, Issue 12
1 Dec 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics